Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections

This review (32 eligible RCTs; individual participant data from 26 trials n=6,708) concludes that use of procalcitonin in this context results in lower risks of mortality, antibiotic consumption and risk for antibiotic-related side effects.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news